Evidence map›Paper›PMID 40060345›Full record

ArticleSouth Asian journal of cancer2024

Evaluation of Applicability of Tumor Budding and Poorly Differentiated Clusters as Additional Prognostic Markers in Colorectal Cancers.

Sagarika Sarkar, Rena Guha, Sudipta Chakrabarti

Abstract read
In one paragraph

Article in South Asian journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sagarika SarkarDepartment of Pathology, Employees State Insurance Post Graduate Institute of Medical Sciences and Research (ESI PGIMSR), Manicktala, Kolkata, West Bengal, India.
Rena GuhaDepartment of Pathology, Prafulla Chandra Sen Government Medical College and Hospital, Arambagh, West Bengal, India.
Sudipta ChakrabartiDepartment of Pathology, Employees State Insurance Corporation (ESIC) Medical College, Bihta, Patna, Bihar, India.ORCID 0000-0002-0265-2892

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Very few studies have assessed tumor budding (TB) and poorly differentiated cell clusters (PDCs) simultaneously in colorectal cancers (CRCs). The goal of this study was to establish a correlation between these two pertinent histological features and to reinforce the importance of their incorporation in routine histopathological reporting of CRC cases as a means to predict clinical outcome. Methods: Resection specimens of colorectal carcinoma were included in the study. Patients who received presurgical therapy, or refused consent were excluded. PDC and TB were evaluated in routine hematoxylin and eosin-stained histopathological sections taken from the advancing edge of the tumor. TB and PDC were reported by selecting a "hotspot" chosen after review of all available slides with invasive tumor. It was then followed by their correlation with other known prognostic factors. Results: Spearman's rho calculator for strength of association between TB and PDC as well as association of TB and PDC individually with known prognostic factors revealed statistical significance. Correlation of TB and PDC with histologic grade, primary tumor (pT), and regional lymph node (pN) stage was done based on one-way analysis of variance calculator, which yielded statistically significant results. Conclusion: Evaluation of these two histological parameters in the same hotspot field at the tumor invasive front plays a fundamental role in the definition of cancer aggressiveness and prediction of tumor behavior.

Indexed as

colorectal cancers (CRC)morphologypoorly differentiated cell cluster (PDC)prognostic markerstumor budding (TB)

Identifiers

PMID40060345
PMCPMC11888805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.